KYLE MEDLIN: Open Payments
NPI 1336532746 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 63 payments from 23 companies in 2025. Trend: 2023 $583 · 2024 $642 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $192 |
| Janssen Biotech, Inc. | 7 | $150 |
| ABBVIE INC. | 8 | $142 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Exelixis Inc. | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Incyte Corporation | 2 | $42 |
| Eisai Inc. | 2 | $40 |
| Iovance Biotherapeutics, Inc. | 2 | $38 |
Products named: EPKINLY, ERLEADA, Fabhalta, KEYTRUDA, SCEMBLIX, Enhertu, CABOMETYX, MONJUVI.
Industry payments across AR — which companies pay providers there.
